Smith Drug Co. v. Actavis (Namenda), No. 15-7488 (S.D.N.Y.)
Smith Drug Co. v. Actavis (Namenda), No. 15-7488 (S.D.N.Y.)
Smith Drug Co. v. Actavis (Namenda), No. 15-7488 (S.D.N.Y.), Faruqi & Faruqi representing a pharmaceutical wholesaler and a proposed class of direct purchasers of Actavis’ Namenda XR, alleging that Actavis Actavis engaged in an illegal product hop to move the market from Namenda to Namenda XR in order to thwart competition from generic Namenda. (settled for $750 million)
Details
Counsel
Joseph T. Lukens
jlukens@faruqilaw.com
Phone (215) 277-5770
Fax (215) 277-5771
Peter Kohn
pkohn@faruqilaw.com
Phone (215) 277-5770
Fax (215) 277-5771
Office
New York
685 Third Avenue 26th Floor
New York New York 10017
Phone (212) 983-9330
Fax (212) 983-9331
